December 19, 2014
In a new report, the Pharmaceutical Research and Manufacturers of America examined the successes and failures of hepatitis C virus infection research and therapies since the infection was discovered 25 years ago.
“Hepatitis C research successes have built over time,” the report said. “Following the identification of the virus in 1989, stepwise improvements in interferon-based therapy ensued over the next two decades…After years of research and many setbacks, the first of these medicines — direct-acting antivirals — were approved in 2011. Since that time, many more of these medicines have been approved and researchers are finding even greater success in employing a combination of antiviral therapies to more effectively combat the disease.”